Vontier Corporation
VNT
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
118.2% upsideUndervalued by 118.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.00 Billion |
|---|---|
| Enterprise Value | $5.79 Billion |
| Dividend Yield | $0.10 (0.35%) |
| Earnings per Share | $2.77 |
| Beta | 1.24 |
| Outstanding Shares | 141,800,000 |
Return
| Return on Equity | 32.77% |
|---|---|
| Return on Assets | 9.98% |
| Return on Invested Capital | 18.54% |
Valuation & Multiples
| P/E Ratio | 9.76 |
|---|---|
| PEG | 133.99 |
| Price to Sales | 1.36 |
| Price to Book Ratio | 3.56 |
| Enterprise Value to Revenue | 1.88 |
| Enterprise Value to EBIT | 10.08 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 1.61 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0126▲ 101.26% |
|---|---|
| Total Calls | 15,900▲ 35.90% |
| Total Puts | 16,100▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 96.64%▼ 3.14% |
|---|---|
| Total Invested | $5.03B▼ 5.80% |
| Investors Holding | 486▼ 6.00% |
ESG Score
No data
About Vontier Corporation
Relevant Senate Committees
Controls taxation, trade, and entitlement spending (e.g., Medicare, Medicaid). Changes in corporate tax policy directly affect Vontier's profitability, while decisions on Medicare pricing and reimbursements profoundly impact the market demand and revenue streams for electromedical devices.
Allocates discretionary federal spending, including for healthcare research (NIH), agencies (FDA), and programs (Medicare/Medicaid reimbursements, VA healthcare). These allocations directly impact the funding available for the development, regulation, and purchase of electromedical devices, critically affecting Vontier's market.
This committee directly regulates the FDA, the primary agency responsible for approving and regulating the manufacturing and sale of electromedical and electrotherapeutic apparatus. Its legislative actions directly impact Vontier's core business operations and product market access.
Oversees the Department of Veterans Affairs (VA), a major purchaser and user of electromedical and electrotherapeutic apparatus. Committee funding decisions directly impact VA hospitals' ability to procure such devices, influencing Vontier's potential revenue.